Eosinophil-cationic protein - a novel liquid prognostic biomarker in melanoma

Krueckel A, Moreira A, Froehlich W, Schuler G, Heinzerling L (2019)


Publication Type: Journal article

Publication year: 2019

Journal

Book Volume: 19

DOI: 10.1186/s12885-019-5384-z

Abstract

BackgroundThe role of eosinophils in cancer is not yet completely understood, but patients with eosinophilia show a trend towards longer survival in several types of cancer, including melanoma. However, eosinophil count at initial diagnosis of metastatic melanoma does not predict survival. Since eosinophil cationic protein (ECP) mediates anticancer effects, such as tissue remodelling and cytotoxic activity, we investigated this marker as an early prognostic marker in metastatic melanoma.MethodsSerum of 56 melanoma patients was collected at the time of diagnosis of metastatic disease. ECP levels as measured by ELISA were correlated with overall survival (OS) in patients before systemic therapy with immunotherapy or chemotherapy. Statistical analyses were performed using the Log-Rank (Mantel-Cox) test.ResultsThe median OS for patients with high serum ECP above 12.2ng/ml was 12months (n=39), compared to 28months for patients with ECP below this threshold (n=17; p=0.0642). In patients with cutaneous melanoma, excluding patients with uveal and mucosal melanoma, the survival difference was even more striking (p=0.0393). ECP's effect size on OS was observed independently of the consecutive therapy. ECP levels were not correlated with LDH levels.ConclusionECP seems to be a novel prognostic serum marker for the outcome of melanoma patients, which is independent of LDH and easy to perform in clinical practice. The striking negative prognostic value of high ECP level is unanticipated and can guide patient management.

Authors with CRIS profile

How to cite

APA:

Krueckel, A., Moreira, A., Froehlich, W., Schuler, G., & Heinzerling, L. (2019). Eosinophil-cationic protein - a novel liquid prognostic biomarker in melanoma. BMC Cancer, 19. https://dx.doi.org/10.1186/s12885-019-5384-z

MLA:

Krueckel, Annika, et al. "Eosinophil-cationic protein - a novel liquid prognostic biomarker in melanoma." BMC Cancer 19 (2019).

BibTeX: Download